These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33271595)

  • 1. Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic.
    Peach E; Rutter M; Lanyon P; Grainge MJ; Hubbard R; Aston J; Bythell M; Stevens S; Pearce F
    Rheumatology (Oxford); 2021 Apr; 60(4):1902-1909. PubMed ID: 33271595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project.
    Rutter M; Lanyon PC; Grainge MJ; Hubbard R; Peach E; Bythell M; Stilwell P; Aston J; Stevens S; Pearce FA
    Rheumatology (Oxford); 2022 Aug; 61(8):3161-3171. PubMed ID: 34698821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project.
    Rutter M; Lanyon PC; Grainge MJ; Hubbard R; Bythell M; Stilwell P; Aston J; McPhail S; Stevens S; Pearce FA
    Rheumatology (Oxford); 2023 Dec; 62(12):3828-3837. PubMed ID: 37018139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
    Nafilyan V; Islam N; Mathur R; Ayoubkhani D; Banerjee A; Glickman M; Humberstone B; Diamond I; Khunti K
    Eur J Epidemiol; 2021 Jun; 36(6):605-617. PubMed ID: 34132940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.
    Joy M; Hobbs FR; Bernal JL; Sherlock J; Amirthalingam G; McGagh D; Akinyemi O; Byford R; Dabrera G; Dorward J; Ellis J; Ferreira F; Jones N; Oke J; Okusi C; Nicholson BD; Ramsay M; Sheppard JP; Sinnathamby M; Zambon M; Howsam G; Williams J; de Lusignan S
    Br J Gen Pract; 2020 Dec; 70(701):e890-e898. PubMed ID: 33077508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.
    Ayoubkhani D; Khunti K; Nafilyan V; Maddox T; Humberstone B; Diamond I; Banerjee A
    BMJ; 2021 Mar; 372():n693. PubMed ID: 33789877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England.
    Nafilyan V; Humberstone B; Mehta N; Diamond I; Coupland C; Lorenzi L; Pawelek P; Schofield R; Morgan J; Brown P; Lyons R; Sheikh A; Hippisley-Cox J
    Lancet Digit Health; 2021 Jul; 3(7):e425-e433. PubMed ID: 34049834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
    Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess mortality in England and Wales during the first wave of the COVID-19 pandemic.
    Kontopantelis E; Mamas MA; Deanfield J; Asaria M; Doran T
    J Epidemiol Community Health; 2021 Mar; 75(3):213-223. PubMed ID: 33060194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study.
    Bosworth ML; Ayoubkhani D; Nafilyan V; Foubert J; Glickman M; Davey C; Kuper H
    Lancet Public Health; 2021 Nov; 6(11):e817-e825. PubMed ID: 34626547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in children: analysis of the first pandemic peak in England.
    Ladhani SN; Amin-Chowdhury Z; Davies HG; Aiano F; Hayden I; Lacy J; Sinnathamby M; de Lusignan S; Demirjian A; Whittaker H; Andrews N; Zambon M; Hopkins S; Ramsay ME
    Arch Dis Child; 2020 Dec; 105(12):1180-1185. PubMed ID: 32796006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts.
    Wong AY; MacKenna B; Morton CE; Schultze A; Walker AJ; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Forbes H; Eggo RM; Parry J; Hester F; Harper S; Evans SJ; Smeeth L; Douglas IJ; Goldacre B;
    Ann Rheum Dis; 2021 Jul; 80(7):943-951. PubMed ID: 33478953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in England: A retrospective cohort study of primary care data.
    Carey IM; Cook DG; Harris T; DeWilde S; Chaudhry UAR; Strachan DP
    PLoS One; 2021; 16(12):e0260381. PubMed ID: 34882700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Risk-Adjusted 28-Day Mortality Rates for Patients Hospitalized with COVID-19 in England.
    Jones S; Mason N; Palser T; Swift S; Petrilli CM; Horwitz LI
    J Hosp Med; 2021 May; 16(5):290-293. PubMed ID: 33617437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Health Management to identify and characterise ongoing health need for high-risk individuals shielded from COVID-19: a cross-sectional cohort study.
    Kenward C; Pratt A; Creavin S; Wood R; Cooper JA
    BMJ Open; 2020 Sep; 10(9):e041370. PubMed ID: 32988953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020.
    Wu J; Mafham M; Mamas MA; Rashid M; Kontopantelis E; Deanfield JE; de Belder MA; Gale CP
    Mayo Clin Proc; 2021 Apr; 96(4):952-963. PubMed ID: 33714592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.
    Atkins JL; Masoli JAH; Delgado J; Pilling LC; Kuo CL; Kuchel GA; Melzer D
    J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2224-2230. PubMed ID: 32687551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
    J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of routine death and illness surveillance data to provide insight for UK pandemic planning: lessons from COVID-19.
    Clough HE; McIntyre KM; Patterson GE; Harris JP; Rushton J
    BMJ Open; 2021 Feb; 11(2):e044707. PubMed ID: 33558359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
    Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.